Hans‐Heinrich Wolf

2.5k total citations
42 papers, 1.3k citations indexed

About

Hans‐Heinrich Wolf is a scholar working on Hematology, Oncology and Epidemiology. According to data from OpenAlex, Hans‐Heinrich Wolf has authored 42 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 13 papers in Oncology and 13 papers in Epidemiology. Recurrent topics in Hans‐Heinrich Wolf's work include Neutropenia and Cancer Infections (8 papers), Antifungal resistance and susceptibility (7 papers) and Platelet Disorders and Treatments (6 papers). Hans‐Heinrich Wolf is often cited by papers focused on Neutropenia and Cancer Infections (8 papers), Antifungal resistance and susceptibility (7 papers) and Platelet Disorders and Treatments (6 papers). Hans‐Heinrich Wolf collaborates with scholars based in Germany, Austria and United States. Hans‐Heinrich Wolf's co-authors include Oliver A. Cornely, Dieter Buchheidt, Georg Maschmeyer, Andrew J. Ullmann, Olaf Penack, Markus Ruhnke, Werner Heinz, William Krüger, Gerda Silling and Stefan W. Krause and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Pain.

In The Last Decade

Hans‐Heinrich Wolf

41 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hans‐Heinrich Wolf Germany 20 480 465 427 347 190 42 1.3k
Mike Potter United Kingdom 24 510 1.1× 186 0.4× 409 1.0× 823 2.4× 157 0.8× 63 1.7k
Xaver Schiel Germany 19 542 1.1× 267 0.6× 570 1.3× 134 0.4× 106 0.6× 36 1.2k
Alain Kentos Belgium 18 288 0.6× 199 0.4× 284 0.7× 330 1.0× 264 1.4× 58 1.4k
Richard Champlin United States 15 299 0.6× 259 0.6× 325 0.8× 870 2.5× 201 1.1× 32 1.5k
Isabel Sánchez‐Ortega Spain 17 404 0.8× 326 0.7× 454 1.1× 374 1.1× 79 0.4× 50 1.1k
Jeffery J. Auletta United States 22 229 0.5× 263 0.6× 369 0.9× 478 1.4× 193 1.0× 115 1.5k
Hamdi Akan Türkiye 26 775 1.6× 602 1.3× 555 1.3× 471 1.4× 93 0.5× 106 1.8k
R Haake United States 28 379 0.8× 192 0.4× 647 1.5× 1.4k 3.9× 141 0.7× 43 2.2k
Shubhra Ghosh United States 13 711 1.5× 274 0.6× 273 0.6× 520 1.5× 54 0.3× 27 1.4k
G Todeschini Italy 19 264 0.6× 214 0.5× 764 1.8× 391 1.1× 87 0.5× 32 1.6k

Countries citing papers authored by Hans‐Heinrich Wolf

Since Specialization
Citations

This map shows the geographic impact of Hans‐Heinrich Wolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans‐Heinrich Wolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans‐Heinrich Wolf more than expected).

Fields of papers citing papers by Hans‐Heinrich Wolf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans‐Heinrich Wolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans‐Heinrich Wolf. The network helps show where Hans‐Heinrich Wolf may publish in the future.

Co-authorship network of co-authors of Hans‐Heinrich Wolf

This figure shows the co-authorship network connecting the top 25 collaborators of Hans‐Heinrich Wolf. A scholar is included among the top collaborators of Hans‐Heinrich Wolf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans‐Heinrich Wolf. Hans‐Heinrich Wolf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Straka, Christian, Hans Salwender, Stefan Knop, et al.. (2021). Full or intensity‐reduced high‐dose melphalan and single or double autologous stem cell transplant with or without bortezomib consolidation in patients with newly diagnosed multiple myeloma. European Journal Of Haematology. 107(5). 529–542. 4 indexed citations
2.
3.
Miesbach, Wolfgang, Sylvia Reitter-Pfoertner, Robert Klamroth, et al.. (2017). Co‐morbidities and bleeding in elderly patients with haemophilia—A survey of the German, Austrian and Swiss Society of Thrombosis and Haemostasis Research (GTH). Haemophilia. 23(5). 721–727. 9 indexed citations
4.
5.
Lilienfeld‐Toal, Marie von, Annemarie Berger, Maximilian Christopeit, et al.. (2016). Community acquired respiratory virus infections in cancer patients—Guideline on diagnosis and management by the Infectious Diseases Working Party of the German Society for haematology and Medical Oncology. European Journal of Cancer. 67. 200–212. 50 indexed citations
6.
Wolf, Hans‐Heinrich, Malte Kornhuber, Joachim Weis, & Andreas Posa. (2016). Dysautonomic polyneuropathy as a variant of chronic inflammatory “demyelinating” polyneuropathy?. Clinical Autonomic Research. 26(4). 303–305.
7.
Mousset, Sabine, Dieter Buchheidt, Werner Heinz, et al.. (2013). Treatment of invasive fungal infections in cancer patients—updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Annals of Hematology. 93(1). 13–32. 121 indexed citations
8.
Jordan, Karin, et al.. (2009). Safety and efficacy of a triple antiemetic combination with the NK-1 antagonist aprepitant in highly and moderately emetogenic multiple-day chemotherapy. European Journal of Cancer. 45(7). 1184–1187. 35 indexed citations
9.
10.
Voigt, Wieland, et al.. (2007). Human Chorionic Gonadotropin-Induced Hyperthyroidism in Germ Cell Cancer – a Case Presentation and Review of the Literature. Oncology Research and Treatment. 30(6). 330–334. 10 indexed citations
11.
Varga, Gyula, Heinz Leibl, Zoltán Gasztonyi, et al.. (2006). Efficacy and Safety of the New Intravenous Immunoglobulin IGIV 10% in Adults with Chronic Idiopathic Thrombocytopenic Purpura. Transfusion Medicine and Hemotherapy. 33(6). 509–514. 13 indexed citations
12.
Penack, Olaf, T. Beinert, Dieter Buchheidt, et al.. (2006). Management of sepsis in neutropenia: guidelines of the infectious diseases working party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Annals of Hematology. 85(9). 639–639. 1 indexed citations
13.
Jordan, Karin, Axel Grothey, Wilfried Grothe, et al.. (2005). Successful treatment of mediastinal lymphomatoid granulomatosis with rituximab monotherapy. European Journal Of Haematology. 74(3). 263–266. 39 indexed citations
14.
Knöll, Martin, et al.. (2005). Outbreak of Vancomycin-Resistant Enterococci (VRE) in a Hematological Oncology Ward and Hygienic Preventive Measures. A Long-Term Study. Oncology Research and Treatment. 28(4). 187–192. 16 indexed citations
15.
Krüger, William, Julia Bohlius, Oliver A. Cornely, et al.. (2005). Antimicrobial prophylaxis in allogeneic bone marrow transplantation. Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Haematology and Oncology. Annals of Oncology. 16(8). 1381–1390. 41 indexed citations
16.
Wolf, Hans‐Heinrich, Michael Borte, Mathieu Caulier, et al.. (2003). Efficacy, tolerability, safety and pharmacokinetics of a nanofiltered intravenous immunoglobulin: studies in patients with immune thrombocytopenic purpura and primary immunodeficiencies. Vox Sanguinis. 84(1). 45–53. 37 indexed citations
17.
Auerswald, Günter, Werner Engl, Christiane Güthner, et al.. (2002). Successful Treatment of Patients with von Willebrand Disease using a High-Purity Double-Virus Inactivated Factor VIII/von Willebrand Factor Concentrate (Immunate®). Seminars in Thrombosis and Hemostasis. 28(2). 203–214. 12 indexed citations
18.
Withold, Wolfgang, M. Arning, Martin Schwarz, Hans‐Heinrich Wolf, & Wolfgang Schneider. (1998). Monitoring of multiple myeloma patients by simultaneously measuring marker substances of bone resorption and formation. Clinica Chimica Acta. 269(1). 21–30. 13 indexed citations
19.
Zucker, Tom-Philipp, et al.. (1998). Patient-controlled versus staff-controlled analgesia with pethidine after allogeneic bone marrow transplantation. Pain. 75(2). 305–312. 16 indexed citations
20.
Wolf, Hans‐Heinrich, et al.. (1990). Preliminary Results of Treatment with Itraconazole in Patients with Systemic Fungal Infections. Hämatologie und Bluttransfusion. 33. 560–562. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mike Potter Breakdown of academic impact, for papers by Xaver Schiel Breakdown of academic impact, for papers by Alain Kentos Breakdown of academic impact, for papers by Richard Champlin Breakdown of academic impact, for papers by Isabel Sánchez‐Ortega Breakdown of academic impact, for papers by Jeffery J. Auletta Breakdown of academic impact, for papers by Hamdi Akan Breakdown of academic impact, for papers by R Haake Breakdown of academic impact, for papers by Shubhra Ghosh Breakdown of academic impact, for papers by G Todeschini
Rankless by CCL
2026